Skip to content
2000
Volume 12, Issue 7
  • ISSN: 0929-8673
  • E-ISSN: 1875-533X

Abstract

Assessment of gene function following the completion of human genome sequencing can be performed with nuclear medicine procedures. These techniques may be applied for the determination of gene function and regulation using established and new tracers or using in vivo reporter genes such as genes encoding enzymes, receptors, antigens, or transporters. Visualization of in vivo reporter gene expression can be done using radiolabeled substrates, antibodies, or ligands. Combinations of specific promoters and in vivo reporter genes may deliver information about the regulation of the corresponding genes. The role of radiolabeled antisense molecules for the analysis of mRNA content has to be investigated. However, possible applications are therapeutic interventions using triplex oligonucleotides with therapeutic isotopes, which can be brought near to specific DNA sequences to induce DNA strand breaks at selected loci. Imaging of labeled siRNA's makes sense if these are used for therapeutic purposes in order to assess the delivery of these new drugs to their target tissue. Pharmacogenomics will identify new surrogate markers for therapy monitoring which may represent potential new tracers for imaging.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0929867053507351
2005-04-01
2025-05-07
Loading full text...

Full text loading...

/content/journals/cmc/10.2174/0929867053507351
Loading

  • Article Type:
    Review Article
Keyword(s): gene expression; gene transfer; imaging; nuclear medicine; radionuclides
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test